Literature DB >> 22674508

[Endourological imaging with narrow band imaging].

C Doehn1.   

Abstract

Narrow band imaging (NBI) is an optical diagnostic procedure which utilizes the narrowing of the wavelength of visible light in the range between 415 and 550 nm. The NBI is mostly used for the diagnostics of inflammation or tumors of the gastrointestinal tract. The first investigations for diagnostics of bladder cancer using NBI date from 2008. Currently data on resection, follow-up and recurrence behavior of bladder cancer are available. In all publications NBI was tested against white light. A randomized study comparing NBI with photodynamic diagnostics has not yet been carried out. In this article current study results on the application of NBI for bladder cancer will be presented.

Entities:  

Mesh:

Year:  2012        PMID: 22674508     DOI: 10.1007/s00120-012-2896-4

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  35 in total

1.  Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study.

Authors:  Dmitry I Daniltchenko; Claus R Riedl; Markus D Sachs; Frank Koenig; Kurosch L Daha; Heinz Pflueger; Stefan A Loening; Dietmar Schnorr
Journal:  J Urol       Date:  2005-12       Impact factor: 7.450

2.  Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5-aminolaevulinic acid.

Authors:  F Koenig; F J McGovern; R Larne; H Enquist; K T Schomacker; T F Deutsch
Journal:  BJU Int       Date:  1999-01       Impact factor: 5.588

3.  Narrow-band imaging flexible cystoscopy in the detection of primary non-muscle invasive bladder cancer: a "second look" matters?

Authors:  Yi-Jun Shen; Yi-Ping Zhu; Ding-Wei Ye; Xu-Dong Yao; Shi-Lin Zhang; Bo Dai; Hai-Liang Zhang; Yao Zhu
Journal:  Int Urol Nephrol       Date:  2011-07-27       Impact factor: 2.370

4.  Evaluation of narrow-band imaging as a complementary method for the detection of bladder cancer.

Authors:  Katsunori Tatsugami; Kentaro Kuroiwa; Toshiyuki Kamoto; Hiroyuki Nishiyama; Jun Watanabe; Satoru Ishikawa; Nobuo Shinohara; Ataru Sazawa; Shoji Fukushima; Seiji Naito
Journal:  J Endourol       Date:  2010-08-14       Impact factor: 2.942

5.  Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder.

Authors:  Edwin Hungerhuber; Herbert Stepp; Martin Kriegmair; Christian Stief; Alfons Hofstetter; Arndt Hartmann; Ruth Knuechel; Alexander Karl; Stefan Tritschler; Dirk Zaak
Journal:  Urology       Date:  2007-02       Impact factor: 2.649

6.  Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer--a multicenter study.

Authors:  Patrice Jichlinski; Louis Guillou; Steinar J Karlsen; Per-Uno Malmström; Dieter Jocham; Bjørn Brennhovd; Eva Johansson; Thomas Gärtner; Norbert Lange; Hubert van den Bergh; Hans-Jürg Leisinger
Journal:  J Urol       Date:  2003-07       Impact factor: 7.450

7.  Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy.

Authors:  Jörg Schmidbauer; Fred Witjes; Nikolaus Schmeller; Roland Donat; Martin Susani; Michael Marberger
Journal:  J Urol       Date:  2004-01       Impact factor: 7.450

8.  [Photodynamic diagnostics in the urinary tract. Consensus paper of the Working Group for Oncology of the German Society for Urology].

Authors:  A Stenzl; D Jocham; P Jichlinski; K Junker; F König; H van den Bergh; B Volkmer; D Zaak; J E Gschwend
Journal:  Urologe A       Date:  2008-08       Impact factor: 0.639

9.  A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences.

Authors:  Harry W Herr; S Machele Donat
Journal:  BJU Int       Date:  2008-09-03       Impact factor: 5.588

10.  Narrow band imaging-assisted transurethral resection for non-muscle invasive bladder cancer significantly reduces residual tumour rate.

Authors:  Evelyne C C Cauberg; Charalampos Mamoulakis; Jean J M C H de la Rosette; Theo M de Reijke
Journal:  World J Urol       Date:  2011-02-25       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.